For myocardial perfusion imaging (MPI), the best test to evaluate hemodynamic changes during stress is an exercise treadmill test. It provides independent prognostic value, including evaluation of ...total exercise time, performance, and capacity; heart rate response during exercise, with ischemia, and in recovery; blood pressure response; myocardial oxygen demand; and assessment of symptoms. Combining these exercise data with perfusion imaging provides the best prognostic value and risk stratification for patients. Although exercise stress testing accompanied by MPI is preferential, it is not always possible since an increasing number of patients cannot exercise to a maximal (symptom-limited) level. Further, there is much evidence in the literature demonstrating a suboptimal, non-symptom-limited (not achieving at least 4-6 min or <85% of maximum predicted heart rate) exercise test performed as part of an MPI study may result in a false-negative outcome. Therefore, pharmacologic stress agents provide an excellent alternative for those patients who cannot achieve an adequate heart rate response or adequately perform physical exercise. This article focuses on considerations for performing stress (exercise and pharmacologic) testing in conjunction with MPI. It is meant to provide a basic overview of the principles of exercise stress testing; discuss the indications, contraindications, patient preparation, and protocols for exercise stress testing; discuss the contraindications, administration protocols, and side effects for vasodilator (adenosine, dipyridamole, and regadenoson) stress testing; and discuss the contraindications, administration protocols, and side effects for dobutamine stress testing.
The noninvasive differentiation between ischemic and nonischemic cardiomyopathy is frequently difficult. We examined the clinical value of stress electrocardiographic gated (ECG-gated) single-photon ...emission computed tomography (SPECT) to identify ischemic cardiomyopathy and detect coronary artery disease (CAD) in 164 patients without known CAD, ejection fraction ≤40% by ECG-gated SPECT, and subsequent coronary angiography. Summed stress, rest, and difference scores were measured from the SPECT studies, and regional wall motion variance was calculated from the ECG-gated images. Sensitivity and 95% confidence intervals for the diagnosis of ischemic cardiomyopathy and for detection of any CAD (>50% diameter stenosis) were estimated using previously defined cutoffs for summed stress score and regional wall motion variance. For the diagnosis of ischemic cardiomyopathy, sensitivity of stress SPECT (summed stress score >8) was 87% (95% confidence interval CI 78 to 95), with a specificity of 63% (95% CI 60 to 82). The addition of wall motion information (summed stress score >8 or regional wall motion variance >0.114) increased sensitivity to 88% (95% CI 80 to 96) and decreased specificity to 45% (95% CI 35 to 55). If reversibility was also taken into account (summed stress score >8, regional wall motion variance >0.114, or summed difference score >0), sensitivity further increased to 94% (95% CI 88 to 100) and specificity decreased to 32% (95% CI 23 to 41). For detection of any CAD, the combined approach using stress perfusion, reversibility, and region of wall motion had a sensitivity of 94% (95% CI 89 to 99) and a specificity of 45% (95% CI 35 to 57). Therefore, ECG-gated SPECT is very sensitive for detection of ischemic cardiomyopathy and CAD among patients with moderate to severe systolic dysfunction.
PDF
